WAY-270360

CAS No. 476633-98-4

WAY-270360( N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide )

Catalog No. M28522 CAS No. 476633-98-4

WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 135 In Stock
10MG 188 In Stock
25MG 332 In Stock
50MG 456 In Stock
100MG 642 In Stock
200MG Get Quote In Stock
500MG 1274 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WAY-270360
  • Note
    Research use only, not for human use.
  • Brief Description
    WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
  • Description
    WAY-270360 is a sirtuin modulator and an epidermal growth factor receptor (EGFR) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    N-[4-(1H-benzimidazol-2-yl)phenyl]-2,4-dimethoxybenzamide
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    476633-98-4
  • Formula Weight
    373.412
  • Molecular Formula
    C22H19N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1ccc(C(=O)Nc2ccc(cc2)-c2nc3ccccc3[nH]2)c(OC)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (Rac)-JBJ-04-125-02

    JBJ-04-125-02 is effective as a single agent in both in vitro and in vivo models of EGFR-mutant lung cancer.

  • EGFR-IN-11

    EGFR-IN-11 is a selective inhibitor of EGFR-tyrosine kinase and induces cell apoptosis. EGFR-IN-11 inhibits triple mutant EGFRL858R/T790M/C797S with an IC50 of 18 nM and arrests cell cycle at G0/G1.

  • Tiotropium Bromide h...

    Tiotropium Bromide hydrate is a monohydrate of tiotropium bromide (Spiriva; Tiova; BA 679BR; tiopropium) that is an anticholinergic and bronchodilator and a muscarinic receptor antagonist.